Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Astria Therapeutics, Inc. (ATXS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/27/2018 |
GN
| Recent Analysis Shows KalVista Pharmaceuticals, IZEA, Sonic Automotive, Catabasis Pharmaceuticals, ANI Pharmaceuticals, and Clovis Oncology Market Influences — Renewed Outlook, Key Drivers of Growth |
| 06/26/2018 |
GN
| Analysis: Positioning to Benefit within The Manitowoc, Omeros, Catabasis Pharmaceuticals, Zayo Group, Covanta Holding, and Seattle Genetics — Research Highlights Growth, Revenue, and Consolidated Results |
| 03/07/2018 |
GN
| Detailed Research: Economic Perspectives on RPC, Catabasis Pharmaceuticals, Zayo Group, Catalent, ARRIS International, and McCormick & Company — What Drives Growth in Today's Competitive Landscape |
| 12/06/2017 |
GN
| Santhera Pharmaceuticals, Summit Therapeutics, Catabasis Pharmaceuticals and Duchenne UK to host Duchenne Muscular Dystrophy Awareness Day |
| 11/13/2017 |
GN
| Analysis: Positioning to Benefit within Catabasis, Flowserve, MGIC Investment, Arrowhead, Silver Spring, and Live Nation – Research Highlights Growth, Revenue, and Consolidated Results |
|
|